Vaccines R&D-2017 Featured Speakers
John Robert Coleman, Codagenix, Inc., USA
Title:
Hira L. Nakhasi, Food and Drug Administration (FDA), USA
Title:
Robert Hopkins, Emergent BioSolutions Inc, USA
Title: Development of Anthrax Vaccines for Post-Exposure Prophylaxis using FDA’s Animal Rule
Michael J Lacy, Emergent BioSolutions Inc, USA
Title:
Steven Singer, Georgetown University, USA
Title: Immune Responses to Giardia Infection
Shahin Gharakhanian, Cambridge Innovation Center, USA
Title:
Siba K. Samal, University of Maryland, USA
Title:
Armando Zuniga, Virometix AG, Switzerland
Title:
Rocky Cranenburgh, Prokarium, UK
Title: Development of an oral, thermo-stable vaccine for plague using the Vaxonella platform
Michael Hust, Technische Universität Braunschweig, Germany
Title:
Alessandro Sette, La Jolla Institute for Allergy and Immunology, USA
Title:
Farshad Guirakhoo, GeoVax, Inc., USA
Title:
Giulio Philip Tarro, Fondazione de Beaumont Bonelli per le ricerche sul cancro, Italy
Title:
Filip Dubovsky, MedImmune USA
Title:
Nora Dellepiane, Serum Institute of India, Switzerland
Title: Challenges for vaccine regulation
Stephen Albert Johnston, The Biodesign Institute ASU, USA
Title:
Ann M. Ginsberg, AERAS, USA
Title:
Samuel Bogoch, Replikins, Ltd., USA
Title:
Vidadi Yusibov, University of Delaware, USA
Title:
Marjorie Robert-Guroff, National Cancer Institute, USA
Title:
Barbara K. Felber, National Cancer Institute, USA
Title:
Ravi A. Madan, National Cancer Institute, USA
Title:
Kwong Y Tsang, National Cancer Institute, USA
Title: Studies of a novel combination of recombinant adenovirus vaccines containing CEA, MUC1 or Brachyura epitopes as an immunotherapyeutic
Duccio Medini, GSK, Italy
Title: Data Science for Vaccines R&D: the meningococcal vaccine Bexsero from discovery to implementation
Title:
Yvonne Saenger, New York Presbyterian Hospital, USA
Title: Immune Biomarker in Early Stage Melanoma
James E. Galen, University of Maryland School of Medicine, USA
Title:
Laurent M. Humeau, Inovio Pharmaceuticals, USA
Title: Advances in DNA Vaccine Developments
Tong-Ming Fu, Merck, USA
Title:
Osama Rahma, Dana-Farber Cancer Institute, USA
Title: Cancer vaccine development
Sophie Barreteau, VitamFero SA, French
Title:
Gustavo Moreira, Technische Universität Braunschweig, Germany
Title:
George N. Pavlakis, National Cancer Institute, USA
Title:
Christopher Heery, National Cancer Institute, USA
Title:
Edmund J. Gosselin, Albany Medical College, USA
Title: Adjuvant-Independent Intranasal Vaccination Via Human FcgmmaRI-Targeted Fusion Protein
Kristina De Paris, UNC at Chapel Hill, USA
Title: The road to a pediatric HIV vaccine
Ali I. Fattom, NanoBio, USA
Title:
Hong Shen, Elsa Biologics, USA
Title:
Shiladitya DasSarma, University of Maryland School of Medicine, USA
Title: Antigen display and therapeutic potential of a buoyant VLP-like nanoparticle
Fusataka Koide, Southern Research, USA
Title: Emerging and Re-emerging Mosquito-Borne Infectious Diseases – The Role of Non-human Primate Models in Vaccine Development
James L. Gulley, National Cancer Institute, USA
Title:
Gunnveig Grødeland, University of Oslo and Oslo University Hospital, Norway
Title: APC-targeting of antigen for increased efficacy of vaccination
James Moon, University of University of Michigan, USA
Title: Nanodisc platform for personalized neo-antigen vaccination
Mario Skiadopoulos, Emergent Biosolutions, USA
Title: Comparative Analysis of the Antibody Threshold of Protection for the Licensed Biothrax Anthrax Vaccine and Other Novel Anthrax Vaccine Candidates
Joost J. Oppenheim, National Cancer Institute, USA
Title: TLR ligands as anti tumor vaccines in mice
Malabi M Venkatesan, Walter Reed Army Institute of Research (WRAIR), USA
Title: WRAIR's Shigella vaccine development
Ahmed Bouzidi, Vaxeal Group, Switzerland
Title: Pre-Clinical Development Of SVX-1 : A Novel Therapeutic Cancer Vaccine
Jean Marie Andrieu, Descartes University, Paris
Title:
Barbara Ensoli, Istituto Superiore di Sanità, Italy
Title:
Ruth Ruprecht, Texas Biomedical Research Institute, USA
Title:
Jay Bream, Johns Hopkins University, USA
Title:
Cyril Gerard Gay, USDA/ARS, USA
Title: Veterinary vaccine research in support of biodefense and the threat of biological threat agents
Mei Cong, Promega Corp, USA
Title:
Klaus Überla, University Hospital Erlangen, Virology Institute, USA
Title:
Moriya Tsuji, Aaron Diamond AIDS Research Center, Rockefeller Univ, USA
Title:
Spyros Kalams, Vanderbilt University Medical Center, USA
Title:
Teri Heiland, Immunomic Therapeutics, USA
Title:
Ursula Buchholz, RNA Viruses Section NIAID, NIH USA
Title: Pediatric live-attenuated RSV vaccine candidates
Nicolas Çuburu, National Cancer Institute, USA
Title: New Viral Vector for Therapeutic Vaccination Against HPV-associated Neoplasia
Jasmin Leshem, National Cancer Institute, USA
Title: Combining Local Immunotoxins Targeting Mesothelin with CTLA-4 Blockade Eradicates Murine Cancer by Promoting Anti-Cancer Immunity
Mahin Khatami, National Cancer Institute (retired), USA
Title: Scientific Analyses of Data on Specific Vaccines and Immunity
Wendy Watford, University of Georgia, USA
Title: Induction of IFN-lambda production and anti-viral activity by the serine-threonine kinase, Tpl2: implications for influenza vaccine development
Ewan Plant, US Food & Drug Administration, USA
Title: How the annual influenza vaccination affects the antibody response to drifted viruses
Leonardo Marino-Ramirez, NIH/NLM/NCBI, USA
Title: Developing Vaccines in the Genomics Era
Andrea Facciabene, University of Pennsylvania, USA
Title: PD-1/PD-L1 antagonism increase efficacy of mitochondria based vaccine
Teresa de los Santos, ARS, USDA, USA
Title: FMD vaccines in the veterinary vaccine section
Amy Rosenberg, US Food & Drug Administration, USA
Title: Rescue of T cell Mediated Vaccine Immunity following Sublethal Irradiation
Scot Roberts, Altimmune, Inc., USA
Title:
Jerald Sadoff, Janssen Vaccines & Prevention B.V., The Netherlands
Title:
Konstantin Virnik, FDA/CBER, USA
Title:
Mariola Fotin-Mleczek, CureVac AG, Germany
Title:
Michael A. Egan, Profectus Biosciences, Inc., USA
Title: Development of the VesiculoVax™-vectored Vaccine Platform to Rapidly Respond to New Epidemic Diseases
Ashley Birkett, PATH Malaria Vaccine Initiative (MVI), USA
Title:
Elisa Scarselli,Nouscom Srl, Italy
Title:
Purnima Dubey, Wake Forest University Health Sciences, USA
Title: Reshaping acellular pertussis vaccine-induced immune responses by the novel adjuvant, BcfA
Paul Keller, FDA - CBER, USA
Title:
Andrea L. Cox, Johns Hopkins University, USA
Title: How close are we to realizing a hepatitis C vaccine- and do we need one?
Adan Rios, University of Texas Medical School in Houston, USA
Title:
Richard Wyatt, Scripps Institute in La Jolla, CA, USA
Title:
Graham Pawelec, University of Tuebingen, Germany
Title: Immune frailty: role of viral infection and impact on vaccination in the elderly
Yongjun Sui, National Cancer Institute, USA
Title: Orally delivered mucosal vaccine targeting colorectal immunity protected SHIV transmission in macaques
Klaus Schwamborn, Valneva, France
Title: Responding to the threat of emergent infectious diseases
Yoshikazu Kurosawa, Fujita Health University, Japan
Title: Analysis of antibody repertoires induced by vaccination with four kinds of H5N1 viruses in twenty volunteers
Laura Hong, Merck, USA
Title: Pivotol role of cellular necrosis in residual cytotoxicity of a recombinant vaccine against Clostridium Difficile
Danushka Kumara Wijesundara, The University of Adelaide, Australia
Title: Cytolytic DNA vaccine to induce antigen cross-presentation by dendritic cells and liver tissue resident memory CD8+ T cells
Adan Rios, The George McGovern Medical School at Houston Texas, USA
Title: Fundamental challenges to the development of an HIV vaccine
Mark C. Poznansky, Harvard Medical School, USA
Title: Accelerated development of a T cell based vaccine for Q Fever
J. Brian Kimble, University of Texas Medical Branch, USA
Title: Deconvolution of neutralizing antibody response induced by a trivalent parainfluenza-vectored ebolavirus vaccine